Jump to content

Strategic therapeutic targeting to overcome venetoclax resistance in aggressive B-cell lymphomas. (Q52582128)

From Wikidata
scientific article published on 17 April 2018
edit
Language Label Description Also known as
default for all languages
No label defined
    English
    Strategic therapeutic targeting to overcome venetoclax resistance in aggressive B-cell lymphomas.
    scientific article published on 17 April 2018

      Statements

      Strategic Therapeutic Targeting to Overcome Venetoclax Resistance in Aggressive B-cell Lymphomas (English)

      Identifiers

       
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      edit